Affiliation:
1. UNIVERSITY OF HEALTH SCIENCES, ERZURUM REGION HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE
Abstract
BACKGROUND/AIMS: Prediabetes is considered a risk factor for diabetes mellitus (DM) and cardiovascular diseases. Complications are also detected during diagnosis in 10-40% of diabetes patients. Diabetic nephropathy is one of the critical microvascular complications of diabetes. Studies have shown that prediabetes is associated with the development of glomerular hyperfiltration and albuminuria, as in the early stages of diabetes. Identifying patients before overt DM occurs is important for early diagnosis and treatment of nephropathy and DM.
The aim of our study is to investigate the presence and frequency of nephropathy in prediabetes patients.
METHODS: Patients who applied to the outpatient internal medicine and endocrinology outpatient clinics and whose random fasting blood sugar was ≥100 mg/dl were evaluated. Oral glucose tolerance test (OGTT) was performed and HbA1C values were measured. 280 patients diagnosed with prediabetes and evaluated for nephropathy were included in the study.
RESULTS: Nephropathy was detected in 81 (28.9%) of the patients. The average HbA1C value of the group with nephropathy was 6.28% (sd: 0.52) and the average HbA1C value of the group without nephropathy was 6.05% (sd: 0.29). The average HbA1C value was found to be significantly higher in the group with nephropathy (p=0.000).
CONCLUSIONS: The fact that nephropathy was detected in 28.9% of the patients showed once again the seriousness of prediabetes. Therefore, patients with prediabetes, especially those with higher HbA1C values, need to be evaluated more carefully in terms of nephropathy and CKD.
Publisher
Cagdas Tip Dergisi: Journal of Contemporary Medicine
Reference15 articles.
1. 1. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Physical therapy. 2008;88(11):1254-64.
2. 2. Diabetes Atlas | International Diabetes Federation [Internet]. [cited 2018 april 05]. https://diabetesatlas.org/atlas/seventh-edition/
3. 3. Çalışma, TEMD Diabetes Mellitus, and Eğitim Grubu. "TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2019. 12." Baskı. Ağustos (2019).
4. 4. Ruggenenti P, Remuzzi G. Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? Nephrol Dial Transplant. 2000 Dec;15(12):1900-2.
5. 5. SeyAhi N, AltIpARMA MR, SüleyMAnlAR G. Türkiye’de Renal Replasman Tedavilerinin Güncel Durumu: Türk Nefroloji Derneği Kayıt Sistemi 2013 Yılı Özet Raporu Current Status of Renal Replacement Therapy in Turkey: A Summary of Turkish Society of Nephrology 2013 Annual Registry Report. Süleymanlar, Gültekin–Ateş, Kenan–Seyahi, Nurhan. 2015.